Combined Electrical Stimulation of the Brain and Muscles for patients with Spinal Cord Injury: an experimental study
- Conditions
- Spinal Cord Diseases
- Registration Number
- RBR-7w3jw35
- Lead Sponsor
- niversidade Estadual de Campinas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Spinal cord injury at any neurological level from C2 to T12 for at least one year. Stable neurological deficit for at least 6 months. Over 18 years of age. Both sexes. Pain at the neurological level of injury or below with a Neuropathic Pain 4 (DN4) scale equal to or greater than 4
Cognitive impairment that prevents the safe completion of electrode training. Neuropathic pain prior to spinal cord injury. Other chronic pain syndromes, especially fibromyalgia and complex regional pain syndrome. Extensive skin lesions that do not allow electrode coupling. Decompensated mood disorder. Epilepsy. Use of a pacemaker
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to observe improvement in chronic pain, as assessed by the Neuropathic Pain Symptoms Inventory (NPSI), McGill Pain Questionnaire (MPQ), and Pain Quality Assessment Questionnaire (PQAS), with a minimum variation of 5% between pre- and post-intervention measurements
- Secondary Outcome Measures
Name Time Method It is expected to observe improvement in quality of life, as assessed by the Short-form Health Survey-36 (SF-36) and Quality of Life Index Spinal Cord Injury III (QoLSCI), with a minimum variation of 5% between pre- and post-intervention measurements;It is expected to observe an increase in muscle strength, as assessed by the peak isometric force, with a minimum variation of 5% between pre- and post-intervention measurements;It is expected to observe a lowering of the level of sensory injury, as assessed by the American Spinal Cord Injury Association Impairment Scale (AIS), with a reduction of at least one sensory dermatome between pre- and post-intervention measurements